BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36509537)

  • 1. [Comparative study of hypersensitive quantitative fecal immunochemical test and qualitative fecal occult blood test for colorectal cancer and advanced adenoma].
    Zhou RC; Wang PZ; Ma MJ; Meng FY; Li YY; Zhang Y; Yang XY; Li YQ; Zuo XL
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(46):3667-3672. PubMed ID: 36509537
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening.
    Yuan SY; Wu W; Fu J; Lang YX; Li JC; Guo Y; Wang YN; Qian JM; Li JN
    J Dig Dis; 2019 Feb; 20(2):78-82. PubMed ID: 30714346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.
    Hundt S; Haug U; Brenner H
    Ann Intern Med; 2009 Feb; 150(3):162-9. PubMed ID: 19189905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary application of the Asia-Pacific colorectal screening score combined with the quantitative fecal occult blood in colorectal neoplasia screening].
    Kang Q; Li N; Wang RF; Yang L; Jin P; Sheng JQ
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3825-3828. PubMed ID: 34895425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison between application of fecal occult blood quantitive testing instrument and colloidal gold strip method in colorectal cancer screening].
    Huang YQ; Zhang MW; Shen YZ; Ma HQ; Cai SR; Zhang SZ; Zheng S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Aug; 47(8):747-51. PubMed ID: 24246083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan.
    Ou CH; Kuo FC; Hsu WH; Lu CY; Yu FJ; Kuo CH; Wang JY; Wu MT; Shiea J; Wu DC; Hu HM
    J Dig Dis; 2013 Sep; 14(9):474-83. PubMed ID: 23701988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.
    Haug U; Hundt S; Brenner H
    Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative immunochemical fecal occult blood test for colorectal neoplasia.
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Leshno M; Niv Y
    Ann Intern Med; 2007 Feb; 146(4):244-55. PubMed ID: 17310048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.
    Park DI; Ryu S; Kim YH; Lee SH; Lee CK; Eun CS; Han DS
    Am J Gastroenterol; 2010 Sep; 105(9):2017-25. PubMed ID: 20502450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic performance of quantitative fecal immunochemical test in detection of advanced colorectal neoplasia].
    Lu M; Chen HD; Liu CC; Zhang YH; Wei LP; Lyu ZY; Ren JS; Shi JF; Zou SM; Li N; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2104-2111. PubMed ID: 33378824
    [No Abstract]   [Full Text] [Related]  

  • 11. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a Single Aspirin Dose Prior to Fecal Immunochemical Testing on Test Sensitivity for Detecting Advanced Colorectal Neoplasms: A Randomized Clinical Trial.
    Brenner H; Calderazzo S; Seufferlein T; Ludwig L; Dikopoulos N; Mangold J; Böck W; Stolz T; Eisenbach T; Block T; Kopp-Schneider A; Czock D; Tikk K
    JAMA; 2019 May; 321(17):1686-1692. PubMed ID: 31063574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical value of multi-target stool fecal immunochemical test-DNA in early screening and diagnosis for colorectal cancer].
    Li YL; Guan X; Dou LZ; Liu Y; Huang HY; Huang SK; Yang ZX; Wei BJ; Wu Y; Chen ZH; Wang GQ; Wang X; Cui W
    Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(33):2607-2613. PubMed ID: 36058686
    [No Abstract]   [Full Text] [Related]  

  • 14. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection.
    Haug U; Knudsen AB; Lansdorp-Vogelaar I; Kuntz KM
    Int J Cancer; 2015 Jun; 136(12):2864-74. PubMed ID: 25403937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
    Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K
    Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
    Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
    Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria.
    Alatise OI; Dare AJ; Akinyemi PA; Abdulkareem FB; Olatoke SA; Knapp GC; Kingham TP;
    Lancet Glob Health; 2022 Jul; 10(7):e1012-e1022. PubMed ID: 35714629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.